FMP
MagForce AG
MF6.DE
XETRA
Inactive Equity
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
0.117 EUR
0 (0%)
About
ceo
Dr. Benjamin J. Lipps
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.magforce.comexchange
XETRA
Description
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
CIK
N/A
ISIN
DE000A0HGQF5
CUSIP
D52002108
Address
Max-Planck-Strasse 3
Phone
49 30 308 380 0
Country
DE
Employee
33
IPO Date
Sep 21, 2007
Key Executives
